InvestorsHub Logo
Followers 33
Posts 2023
Boards Moderated 0
Alias Born 06/30/2011

Re: sub360 post# 1195

Saturday, 03/11/2017 1:29:03 PM

Saturday, March 11, 2017 1:29:03 PM

Post# of 1738
No panic people get excited and sell are making a big, big mistake. To me there is nothing wrong here. More people are interested in buy this at a low price and hold to get there return to grow in multiples in time to come. Please read this passage carfully to understand the potential of this company to do extremely well in a short time frame but you have to be patient.
Read this: A number of large investors have recently added to or reduced their stakes in the stock. State Treasurer State of Michigan increased its stake in Evoke Pharma by 460.0% in the third quarter. State Treasurer State of Michigan now owns 140,000 shares of the specialty pharmaceutical company’s stock worth $316,000 after buying an additional 115,000 shares during the last quarter. Vanguard Group Inc. increased its stake in Evoke Pharma by 5.0% in the second quarter. Vanguard Group Inc. now owns 62,381 shares of the specialty pharmaceutical company’s stock worth $427,000 after buying an additional 2,947 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Evoke Pharma by 2.0% in the second quarter. Bank of New York Mellon Corp now owns 23,679 shares of the specialty pharmaceutical company’s stock worth $162,000 after buying an additional 464 shares during the last quarter. 5.13% of the stock is currently owned by institutional investors.
What does it indicate all the big investors are buy and holding becouse they know what this is going be when FDA approve the drug for marking.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVOK News